RE:RE:ONCY pelareorep selected for Phase 3 Pancreatic Cancer trialFrom PanCan's website .."Precision Promise is designed to serve as a catalyst to accelerate pancreatic cancer drug development, de-risk industry participation, increase clinical trial enrollment and transform the way clinical research is done for pancreatic cancer patients."